MoCRA Explained: Understanding New FDA Cosmetic Regulations | AIChE

MoCRA Explained: Understanding New FDA Cosmetic Regulations

Authors 

Bellomo, J. - Presenter, Registrar Corp
In December 2022, U.S. Congress passed a bill that will forever change the FDA’s authority over cosmetic regulations in the United States. The Modernization of Cosmetics Regulation Act of 2022 (known as “MoCRA”) focuses on provisions that will require domestic and foreign firms to register with US FDA, designate a US Agent for FDA communications, “list” their products, collect and report serious adverse events to US FDA, and many other transparency and safety elements.

With 2024 set to provide more insight into other regulations around Good Manufacturing Practices, Fragrance Allergens, and Labeling requirements, it is important to understand the compliance deadlines and requirements and how they apply to your business.

Though there are still many unknowns, there are steps companies can take now to prepare and educate themselves on what these changes mean to their business. In this seminar, it will outline what the new requirements mean to facilities and Responsible Persons, and how this will transform the industry for the years ahead.

Checkout

This paper has an Extended Abstract file available; you must purchase the conference proceedings to access it.

Checkout

Do you already own this?

Pricing

Individuals

AIChE Pro Members $95.00
AIChE Graduate Student Members $95.00
AIChE Undergraduate Student Members $95.00
AIChE Explorer Members $95.00
Non-Members $95.00